The Significance of Isolation of Saprophytic Molds from the Lower Respiratory Tract in Patients with Cancer: How Do the European Organization for Research and Treatment of Cancer/Mycoses Study Group Criteria Apply?

Cancer

Volumn 100, Issue 1, 2004, Pages 165-172

  Lionakis, Michail S ^a   Kontoyiannis, Dimitrios P ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Invasive mold infections; Patients with cancer; Respiratory tract cultures; Saprophytic molds

Indexed keywords

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CLADOSPORIUM; CORTICOSTEROID THERAPY; CULTURE MEDIUM; FEMALE; FUNGUS CULTURE; HIGH RISK PATIENT; HUMAN; LEUKEMIA; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MOULD; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHUMAN; PAECILOMYCES; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SCEDOSPORIUM APIOSPERMUM; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW TRANSPLANTATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUNGI; HUMANS; LEUKEMIA; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; NEOPLASMS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; SCEDOSPORIUM;

EID: 0348108288     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11876     Document Type: Article

References (35)

1. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001;32:1319-1324.
2. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mold infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909-917.
3. Krcmery V Jr., Kunova E, Jesenska Z, et al. Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections. Support Care Cancer. 1996;4:39-45.
4. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis. 2002;21:161-172.
5. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996;23:608-615.
6. Morrison VA, Haake RJ, Weisdorf DJ. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore). 1993;72:78-89.
7. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
8. Bodey GP, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis. 1992;11:99-109.
9. Bartlett JG. Aspergillosis update. Medicine (Baltimore). 2000; 79:281-282.
10. Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive mold infections using culture, histologic, and cytologic examination: evidence of poor yield. Am J Clin Pathol. In press.
11. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997; 175:1459-1466.
12. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824-1833.
13. Munoz P, Alcala L, Sanchez Conde M, et al. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation. 2003;75:326-329.
14. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996;100:171-178.
15. Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 1980;11:370-376.
16. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med. 1986;81:249-254.
17. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med. 1992;86:243-248.
18. Torres HA, Kontoyiannis DP. Hyalohyphomycoses (other than aspergillosis and penicilliosis). In: Dismukes WE, Pappas PG, Sobel JD, editors. Oxford textbook of clinical mycology, 1st edition. New York: Oxford University Press, 2003: 252-270.
19. Jahagirdar BN, Morrison VA. Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients. Semin Respir Infect. 2002;17:113-120.
20. Groll AH, Walsh TJ. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect. 2001;7 Suppl 2:8-24.
21. Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467-476.
22. Fleming RV, Walsh TI, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am. 2002;16: 915-933.
23. Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (anamorph Scedosporium apiospermum). Infections in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002;81:333-348.
24. Garcia-Diaz JB, Baumgarten K. Phaeohyphomycotic infections in solid organ transplant patients. Semin Respir Infect. 2002;17:303-309.
25. Ellison MD, Hung RT, Harris K, Campbell BH. Report of the first case of invasive fungal sinusitis caused by Scopulariopsis acremonium: review of Scopulariopsis infections. Arch Otolaryngol Head Neck Surg. 1998;124:1014-1016.
26. Gucalp R, Carlisle P, Gialanella P, Mitsudo S, McKitrick J, Dutcher J. Paecilomyces sinusitis in an immunocompromised adult patient: case report and review. Clin Infect Dis. 1996;23:391-393.
27. Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis. 2002;35:1360-1367.
28. Lavone DH. Medically important fungi: a guide to identification (3rd edition). Washington, DC: American Society for Microbiology Press, 1995.
29. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30:851-856.
30. Musa MO, Al Eisa A, Halim M, et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol. 2000;108:544-548.
31. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol. 2001;19: 253-259.
32. Subira M, Martino R, Rovira M, Vazquez L, Serrano D, De La Camara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol. 2003;82:80-82.
33. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomarman as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 2001;97:1604-1610.
34. Hebart H, Loffler J, Meisner C, et al. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis. 2000;181:1713-1719.
35. Walsh TJ, Chanock SJ. Diagnosis of invasive fungal infections: advances in nonculture systems. Curr Clin Top Infect Dis. 1998;18:101-153.